Please assess the completion status of the following clinical trial:

Trial Title: Pain Control After Cardiac Surgery Using Intravenous Acetaminophen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* - Males or females 18 years of age or older.~* Non-emergency cardiac surgery via a midline sternotomy at Cleveland Clinic Main Campus.~Exclusion Criteria:~1. Redo cardiac surgery.~2. Combined CABG (Coronary Artery Bypass Graft)\& valve replacement, multiple valve replacements, Ascending aortic or aortic arch surgery.~3. Weight \< 50 Kg or Body mass index \> 38 kg/m2.~4. Left ventricle EF ¡Ü 35% ,Right ventricular moderate or severe dysfunction.~5. Severe (3-4 +) Tricuspid Regurgitation.~6. Recent stroke (within 6 months).~7. Severe lung disease requiring home O2 therapy.~8. Preoperative renal insufficiency (Creatinine \> 2.0) or on dialysis.~9. History of liver cirrhosis or active liver disease.~10. Chronic pain conditions controlled by preoperative opioid administration.~11. Known allergy to acetaminophen or fentanyl.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- IV Acetaminophen (Type: EXPERIMENTAL): Patients will receive up to four doses of IV Acetaminophen (1000mg)every six hours after surgery along with standard PCA (patient controlled) opioids.
- Placebo (Type: PLACEBO_COMPARATOR): Patients will receive up to four doses of IV placebo every six hours after surgery along with standard PCA (patient controlled) opioids.

Based on this trial design, predict the completion outcome and termination type (if applicable).